Simultaneous determination of citalopram and tadalafil by the second derivative synchronous fluorescence method in biological fluids; application of Box–Behnken optimization design
- 17 July 2020
- journal article
- research article
- Published by Wiley in Luminescence
- Vol. 36 (1) , 57-65
Abstract
This is the first study focusing solely on that determination of tadalafil in the presence of citalopram as an antidepressant drug. The determination in biological fluids of a co‐administered antidepressant drug and a sexual stimulation drug is a very critical and important step for psychotic and ischaemic heart disease patients, especially in cases of emergency and this requires therapeutic drug monitoring. A sensitive, efficient and rapid assay was selected satisfactorily and applied for simultaneous determination of citalopram and tadalafil either in their pure forms, in tablet dosage forms or in spiked human plasma. There was a large overlap for both drugs, forming the broad band found in conventional fluorescence spectra and their related synchronous fluorescence intensity. Therefore, the development of a highly sensitive second derivative synchronous fluorescence method was demonstrated that removed this overlap. The proposed method depended on measuring the amplitudes of the second derivative of synchronous fluorescence intensity at suitable wavelengths of 301 nm and 367 nm for citalopram and tadalafil at Δλ = 60 nm, respectively. Box–Behnken design as a response surface methodology was used to fit models and create an optimization process encompassing a set of factors and resulting in an optimum response value specifically designed for this method. Under optimum conditions, the linear dynamic ranges for citalopram and tadalafil estimation were 20–900 and 5–400 ng ml−1 with detection limits of 5.40 and 1.43 ng ml−1, respectively.Keywords
This publication has 37 references indexed in Scilit:
- SIMULTANEOUS DETERMINATION OF ILAPRAZOLE AND ITS RELATED COMPOUNDS IN PHARMACEUTICAL DOSAGE FORMS BY UPLCJournal of Liquid Chromatography & Related Technologies, 2013
- Spectrophotometric determination of tadalafil in pure and dosage formsChemical Industry and Chemical Engineering Quarterly, 2011
- Antidepressant-associated sexual dysfunction: impact, effects, and treatmentDrug, Healthcare and Patient Safety, 2010
- Tadalafil for Treatment of Erectile Dysfunction in Men on AntidepressantsJournal of Clinical Psychopharmacology, 2007
- Novel method for determination of trace amounts of citalopram in tablets by fast fourier continuous cyclic voltammetry at au microelectrode in flowing solutionsJournal of the Brazilian Chemical Society, 2007
- Electrochemical Determination of Citalopram by Adsorptive Stripping Voltammetry–Determination in Pharmaceutical ProductsAnalytical Letters, 2006
- EAU Guidelines on Erectile Dysfunction: An UpdateEuropean Urology, 2006
- A REVERSED-PHASE HPLC METHOD DEVELOPMENT FOR THE SEPARATION OF NEW ANTIDEPRESSANTSJournal of Liquid Chromatography & Related Technologies, 2002
- Determination of thiamine, riboflavin and pyridoxine in pharmaceuticals by synchronous fluorescence spectrometry in organized mediaAnalytica Chimica Acta, 2001
- CitalopramDrugs, 1991